LENZ Therapeutics, Inc.
LENZ
$38.63
-$1.06-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.43% | 12.19% | 46.60% | 45.90% | 30.37% |
| Total Depreciation and Amortization | 5.56% | 620.00% | 525.00% | 150.00% | 350.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.74% | -12.57% | 184.73% | 1,039.73% | 228.87% |
| Change in Net Operating Assets | 123.04% | 67.06% | 11.64% | -121.14% | -717.23% |
| Cash from Operations | 27.14% | 32.95% | 56.71% | 19.15% | -16.79% |
| Capital Expenditure | -80.45% | -- | -- | -- | -454.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.82% | 5.55% | -177.20% | -246.34% | -265.93% |
| Cash from Investing | 99.58% | 4.94% | -178.18% | -247.38% | -266.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.92% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 97.71% | -- |
| Cash from Financing | 1,339.49% | -99.97% | 102.77% | 5,349.65% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.52% | -98.26% | -170.99% | -36.17% | -187.93% |